Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schaper

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Dalton Transactions (Cambridge, England : 2003)|September 19, 2017
Sulfonato-imino copper(ii) complexes: fast and general Chan-Evans-Lam coupling of amines and anilinesV Hardouin Duparc, F Schaper
Gene|November 18, 1994
A new hybrid promoter directs transcription at identical start points in mammalian cells and in vitroW Dirks, F Schaper, H Hauser
Der Internist|January 18, 2007
[History and definition(s) of metabolic syndrome]M Hanefeld, F Schaper, A Ceriello
Atherosclerosis|June 25, 1999
Diminished susceptibility to in vitro oxidation of low-density lipoproteins in hypercholesterolemia: key role of alpha-tocopherol contentW Leonhardt, M Hanefeld, F Schaper
Nucleic Acids Research|June 25, 1993
Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genesS Kirchhoff, F Schaper, H Hauser
Clinical Endocrinology|February 13, 2001
Does glucagon have a lipolytic effect?L Ranganath, F Schaper, R Gama, et al.
Cytotechnology|February 24, 2012
Proliferation control of mammalian cells by the tumor suppressor IRF-1M Köster, S Kirchhoff, F Schaper, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 10, 2011
Effects of pioglitazone versus simvastatin on biomarkers of inflammation in patients on high cardiovascular riskM Hanefeld, F Schaper, D Appelt, et al.
Clinical Endocrinology|September 1, 1999
Mechanism of glucagon-induced nauseaL Ranganath, F Schaper, R Gama, et al.
Biochimie|December 29, 1998
In vivo formation of IRF-1 homodimersS Kirchhoff, F Schaper, A Oumard, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Dalton Transactions (Cambridge, England : 2003)|September 19, 2017
Sulfonato-imino copper(ii) complexes: fast and general Chan-Evans-Lam coupling of amines and anilinesV Hardouin Duparc, F Schaper
Gene|November 18, 1994
A new hybrid promoter directs transcription at identical start points in mammalian cells and in vitroW Dirks, F Schaper, H Hauser
Der Internist|January 18, 2007
[History and definition(s) of metabolic syndrome]M Hanefeld, F Schaper, A Ceriello
Atherosclerosis|June 25, 1999
Diminished susceptibility to in vitro oxidation of low-density lipoproteins in hypercholesterolemia: key role of alpha-tocopherol contentW Leonhardt, M Hanefeld, F Schaper
Nucleic Acids Research|June 25, 1993
Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genesS Kirchhoff, F Schaper, H Hauser
Clinical Endocrinology|February 13, 2001
Does glucagon have a lipolytic effect?L Ranganath, F Schaper, R Gama, et al.
Cytotechnology|February 24, 2012
Proliferation control of mammalian cells by the tumor suppressor IRF-1M Köster, S Kirchhoff, F Schaper, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 10, 2011
Effects of pioglitazone versus simvastatin on biomarkers of inflammation in patients on high cardiovascular riskM Hanefeld, F Schaper, D Appelt, et al.
Clinical Endocrinology|September 1, 1999
Mechanism of glucagon-induced nauseaL Ranganath, F Schaper, R Gama, et al.
Biochimie|December 29, 1998
In vivo formation of IRF-1 homodimersS Kirchhoff, F Schaper, A Oumard, et al.
Pageof 6